OptiBiotix Health PLC's (LON:OPTI) Stephen O'Hara speaks to Proactive's Andrew Scott after announcing thy've amended its relationship with CTC Group, the company that is distributing and selling its CholBiomex3 product in the Philippines. The new agreement extends the product range from the distribution of CholBiomeX3 to include LPLDL as a bulk ingredient and three additional products: CholBiome, CholBiomeBP and CholBiomeVH. O'Hara also discusses an extension to its agreement with Draco Ingredients to include a second product.
OptiBiotix Health expands key deals for its WellBiome and CholBiome
Quick facts: OptiBiotix Health PLC
Price: 51.38 GBX
Market Cap: £45.18 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE